UROLOGY

Biotech, Inc. has extensive experience in planning and implementing Phase I-IV programs for urology studies across multiple countries and sites.

Our global investigator network includes urologists, nephrologists, internists and obstetricians/gynecologists. Close working relationships with these investigators and sites ensure our ability to conduct a preliminary feasibility assessment quickly in order to predict enrollment and identify potential challenges for a viable protocol.

With global experience across multiple urology indications, we have conducted trials in recent years in the following:

• Benign prostatic hyperplasia (BPH) / lower urinary tract symptoms (LUTS)
• Erectile dysfunction
• Chronic and acute kidney and renal disease
• Osteoporosis
• Overactive bladder
• Premature ejaculation